METHOD OF TREATING OESOPHAGEAL CANCER Russian patent published in 2013 - IPC A61K31/167 A61K31/513 A61K31/713 A61P35/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely oncology and concerns treating oesophageal cancer. That is ensured by the intravenous introduction of 5-fluoruracil twice a week, 300 mg/m in one introduction every 2-3 days in a combination with the oral introduction of Coletex-gel-DNA-L 10-15 ml 3 times a day. On the other days of week, the hydrogel material Hydrogel Tissue Coletex-5-ftur is introduced in a dose 5 ml once a day; 10-15 min before the introduction of the gel material, Coletex-gel-DNA-L 10-15 ml is additionally introduced. Length of the therapeutic course is 4 weeks.

EFFECT: method provides higher effectiveness of the treatment ensured by a higher dose of cytostatic with reduced general toxicity and side effects.

2 ex